Literature DB >> 15919698

Resolution of renal allograft-associated post-transplant lymphoproliferative disorder with the introduction of sirolimus.

Jeffrey S Zaltzman1, Ramesh Prasad, Kathy Chun, Serge Jothy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15919698     DOI: 10.1093/ndt/gfh884

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  5 in total

Review 1.  mTOR inhibitors in pediatric kidney transplantation.

Authors:  Lars Pape; Thurid Ahlenstiel
Journal:  Pediatr Nephrol       Date:  2013-06-07       Impact factor: 3.714

Review 2.  mTOR inhibitors and renal allograft: Yin and Yang.

Authors:  Gianluigi Zaza; Simona Granata; Paola Tomei; Valentina Masola; Giovanni Gambaro; Antonio Lupo
Journal:  J Nephrol       Date:  2014-05-08       Impact factor: 3.902

3.  Activation of mTORC1 signaling pathway in AIDS-related lymphomas.

Authors:  Mouna El-Salem; Puthiyaveettil N Raghunath; Michal Marzec; Xiaobin Liu; Monika Kasprzycka; Erle Robertson; Mariusz A Wasik
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

4.  Simultaneous inhibition of mTOR-containing complex 1 (mTORC1) and MNK induces apoptosis of cutaneous T-cell lymphoma (CTCL) cells.

Authors:  Michal Marzec; Xiaobin Liu; Maria Wysocka; Alain H Rook; Niels Odum; Mariusz A Wasik
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

5.  Histological spectrum of pulmonary manifestations in kidney transplant recipients on sirolimus inclusive immunosuppressive regimens.

Authors:  Sean Kirby; Anjali Satoskar; Sergey Brodsky; Amy Pope-Harman; David Nunley; Charles Hitchcock; Ronald Pelletier; Patrick Ross; Tibor Nadasdy; Konstantin Shilo
Journal:  Diagn Pathol       Date:  2012-03-14       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.